ivWatch Sensor: Device Validation for Infiltrated Tissues
Launched by IVWATCH, LLC · Aug 20, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed Consent
- • Pass health screen by clinician
- • 18 years or older
- Exclusion Criteria:
- • Fail health screen
About Ivwatch, Llc
ivwatch, LLC is a pioneering medical technology company dedicated to enhancing patient safety and improving clinical outcomes through innovative intravenous (IV) monitoring solutions. With a focus on real-time detection of IV infiltration and extravasation, ivwatch aims to reduce the risks associated with intravenous therapies. The company's flagship product leverages advanced sensor technology and data analytics to provide healthcare professionals with timely alerts, allowing for prompt intervention. Committed to advancing healthcare standards, ivwatch collaborates with clinical partners to conduct rigorous clinical trials and drive evidence-based practices in IV administration.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Williamsburg, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials